Cann Group (CAN) Stock Price, News & Analysis

Company Overview

Cann Group Limited engages in the breeding, cultivation, production, manufacturing, supplying, and selling medicinal cannabis. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: $17.48 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CAN Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Cann Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cann Group investors own include JPMorgan Equity Premium Income ETF (JEPI), Global X Russell 2000 Covered Call ETF (RYLD), Innovative Industrial Properties (IIPR), Invesco QQQ (QQQ), GoHealth (GOCO), BlackRock Innovation and Growth Term Trust (BIGZ) and Global X Nasdaq 100 Covered Call ETF (QYLD).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Electronic Equipment
• Current Symbol: ASX:CAN
• CIK: N/A
• Web: www.canngrouplimited.com
• Phone: 61 3 9095 7088
• Fax: N/A
• Employees: 350
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): A($0.12)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$51.24 million
• Net Margins: -292.38%
• Pretax Margin: N/A
• Return on Equity: -159.56%
• Return on Assets: -13.79%

Debt

• Debt-to-Equity Ratio: 520.55
• Current Ratio: 0.21
• Quick Ratio: 0.54

Sales & Book Value

• Annual Sales: $18.36 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.03 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 468,940,000
• Free Float: N/A
• Market Cap: $17.48 million
• Optionable: Not Optionable
• Beta: 1.09